EMILY HALL: Open Payments
NPI 1326310756 · DALTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$465 in 23 payments from 7 companies in 2025. Trend: 2023 $1,007 · 2024 $977 · 2025 $465
Food & beverage: $465
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $176 |
| Novartis Pharmaceuticals Corporation | 5 | $103 |
| GENZYME CORPORATION | 2 | $90 |
| Galderma Laboratories, L.P. | 2 | $42 |
| Organon LLC | 1 | $28 |
| Lilly USA, LLC | 1 | $21 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $4 |
Products named: SKYRIZI, COSENTYX, DUPIXENT, RINVOQ, NEMLUVIO, VTAMA, TALTZ.
Industry payments across GA — which companies pay providers there.
